A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 von Foster, Graham R., Chayama, Kazuaki, Chuang, Wan-Long, Fainboim, Hugo, Farkkila, Martti, Gadano, Adrian, Gaeta, Giovanni B., Hézode, Christophe, Inada, Yukiko, Heo, Jeong, Kumada, Hiromitsu, Lu, Sheng-Nan, Marcellin, Patrick, Moreno, Christophe, Roberts, Stuart K., Strasser, Simone I., Thompson, Alexander J., Toyota, Joji, Paik, Seung Woon, Vierling, John M., Zignego, Anna L., Cohen, David, McPhee, Fiona, Wind-Rotolo, Megan, Srinivasan, Subasree, Hruska, Matthew, Myler, Heather, Portsmouth, Simon D.

Volltext

The renaissance of fixed dose combinations: Combivir von Portsmouth, Simon D, Scott, Christopher J

Volltext

A randomized, controlled study of peginterferon lambda-1a/ribavirin plus or minus daclatasvir for hepatitis C virus genotype 2 or 3 von Foster, Graham R, Chayama, Kazuaki, Chuang, Wan-Long, Fainboim, Hugo, Farkkila, Martti, Gadano, Adrian, Gaeta, Giovanni B, Hezode, Christophe, Inada, Yukiko, Heo, Jeong, Kumada, Hiromitsu, Lu, Sheng-Nan, Marcellin, Patrick, Moreno, Christophe, Roberts, Stuart K, Strasser, Simone I, Thompson, Alexander J, Toyota, Joji, Paik, Seung Woon, Vierling, John M, Zignego, Anna L, Cohen, David, McPhee, Fiona, Wind-Rotolo, Megan, Srinivasan, Subasree, Hruska, Matthew, Myler, Heather, Portsmouth, Simon D

Volltext

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents von Hayden, Frederick G, Sugaya, Norio, Hirotsu, Nobuo, Lee, Nelson, de Jong, Menno D, Hurt, Aeron C, Ishida, Tadashi, Sekino, Hisakuni, Yamada, Kota, Portsmouth, Simon, Kawaguchi, Keiko, Shishido, Takao, Arai, Masatsugu, Tsuchiya, Kenji, Uehara, Takeki, Watanabe, Akira

Volltext

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomis... von Bassetti, Matteo, Echols, Roger, Matsunaga, Yuko, Ariyasu, Mari, Doi, Yohei, Ferrer, Ricard, Lodise, Thomas P, Naas, Thierry, Niki, Yoshihito, Paterson, David L, Portsmouth, Simon, Torre-Cisneros, Julian, Toyoizumi, Kiichiro, Wunderink, Richard G, Nagata, Tsutae D

Volltext

Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza von Uehara, Takeki, Hayden, Frederick G, Kawaguchi, Keiko, Omoto, Shinya, Hurt, Aeron C, De Jong, Menno D, Hirotsu, Nobuo, Sugaya, Norio, Lee, Nelson, Baba, Keiko, Shishido, Takao, Tsuchiya, Kenji, Portsmouth, Simon, Kida, Hiroshi

Volltext

Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program von Satlin, Michael J, Simner, Patricia J, Slover, Christine M, Yamano, Yoshinori, Nagata, Tsutae D, Portsmouth, Simon

Volltext

Etiology and Natural History of Neutropenia in Human Immunodeficiency Virus Disease: A Prospective Study von Moore, David A. J., Benepal, Tim, Portsmouth, Simon, Gill, Jaz, Gazzard, Brian G.

Volltext

Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures von BENZIE, Andrew A, BANSI, Loveleen K, ORKIN, Chloe, DUNN, David, DELPECH, Valerie, TAYLOR, Graham P, WALSH, John C, PHILLIPS, Andrew N, SABIN, Caroline A, PORTSMOUTH, Simon, HILL, Teresa, JOHNSON, Margaret, GILSON, Richard, EASTERBROOK, Philippa, GAZZARD, Brian, FISHER, Martin

Volltext

The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma von ESDAILE, Ben, DAVIS, Matt, PORTSMOUTH, Simon, SARKER, Debashis, NELSON, Mark, GAZZARD, Brian, BOWER, Mark

Volltext